Development of an Online-Exclusive Açai and Fucoxanthin Product and Joint Patent
First written in FY2017-Q3. 2 of 6 entries say "Restated". Latest entry: FY2022.
0 other companies' latest entry also says "Restated".
- FY2022RestatedAnnual report
「The Company will work to expand sales through the development of functional products such as supplements for its online store and the acquisition of recurring customers in the DM business.」
The policy of improving profitability through the development of online-exclusive functional products and the acquisition of recurring customers remains in place. - FY2021-Q3RestatedAnnual report
「Going forward, the Company will introduce functional products such as supplements exclusively for its online store and work to improve profitability. It is also investing in personnel to improve the customer journey, UI/UX, cross-selling and upselling on its e-commerce site, with the aim of building an e-commerce site that attracts more customers and makes purchasing easier.」
The Company continues to pursue the introduction of online-exclusive functional products and improvements to the e-commerce site's customer journey, UI/UX, cross-selling and upselling. No results, such as the completion of a new product launch, have been reported. - FY2021-Q1ReframedAnnual report
「Going forward, the Company will also seek to develop and sell functional products such as supplements in partnership with experienced external online-sales staff, while pursuing measures to increase customer satisfaction and improve profitability.」
The Company has described a broader functional-product plan, moving from online-exclusive products centered on açai and fucoxanthin to functional products such as supplements developed in partnership with external online-sales staff. - FY2019Reformulation of the Functional New Product PlanAnnual report
「In addition, for the following fiscal year, the Company will move forward with the launch of a profitable product developed exclusively for its online store, incorporating new açai functionality scheduled to be presented at an academic conference.」
After the previous delay in commercialization caused by production technology issues, the Company presented plans for an online-exclusive product incorporating new functionality scheduled to be presented at an academic conference in the following fiscal year. - FY2017SoftenedAnnual report
「The Company is taking time to resolve production technology issues and expects that product commercialization will take some time.」
The policy of developing the jointly patented, online-exclusive product remains in place, but production technology issues pushed back the commercialization schedule. - FY2017-Q3First statedAnnual report
「In November 2016, the Company jointly filed a patent application with Phytolox Co., Ltd. (head office: Uruma, Okinawa; Representative Director: Ito Fumihiro (伊藤 史絋)) for the stabilization of fucoxanthin using açai. The Company is also developing an online-exclusive product using açai and fucoxanthin and is working toward sales from the following fiscal year onward.」
The Company first disclosed a joint patent application concerning fucoxanthin stabilization, along with the development of an online-exclusive product and plans to begin sales from the following fiscal year onward.